Pharmacological role of the atenolol/nifedipine combination in hypertensive patients;Interets pharmacologiques de l'association atenolol/nifedipine chez les patients hypertendus

Drugs

Volumn 56, Issue SUPPL. 2, 1998, Pages 23-30

  Carre, A ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ION; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NIFEDIPINE; RENIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT;

ALDOSTERONE BLOOD LEVEL; ANGINA PECTORIS; ATHEROSCLEROTIC PLAQUE; BRONCHOSPASM; CALCIUM TRANSPORT; CARBOHYDRATE METABOLISM; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CORONARY ARTERY DILATATION; DIURESIS; DRUG EFFICACY; HEART PROTECTION; HUMAN; HYPERTENSION; HYPOGLYCEMIA; INOTROPISM; KIDNEY BLOOD FLOW; KIDNEY PLASMA FLOW; LIPID METABOLISM; META ANALYSIS; NATRIURESIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENIN RELEASE; REVIEW; SUSTAINED RELEASE PREPARATION; VASOCONSTRICTION; DRUG COMBINATION;

ANGINA;

ADRENERGIC BETA-ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; ATENOLOL; CALCIUM CHANNEL BLOCKERS; DRUG THERAPY, COMBINATION; HUMANS; NIFEDIPINE;

EID: 0032238682     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199856002-00003     Document Type: Review

References (20)

1. 1. BJ Materson RA Preston DJ Reda 1994 Results of combination antihypertensive therapy after failure of each of the components Am J Hypertens 7 34A Materson BJ, Preston RA, Reda DJ. Results of combination antihypertensive therapy after failure of each of the components. Am J Hypertens 1994; 7: 34A
2. 2. Gilgenkranz JM, Royer RJ, Zannad F. Thérapeutique en pathologie cardio-vasculaire. Médecine-Sciences Flammarion, Paris, 1987
3. 3. Carré AG, Bertrand ME, Lekieffre JR Effets hémodynamiques aigus et action sur l’activité rénine plasmatique de plusieurs bêta-bloquants récents dans l’hypertension artérielle: comparaison avec les effets du Propranolol [abstract]. Fifth Scientific Meeting of the International Society of Hypertension. Paris, June 12–14 1978: 47
4. 4. FR Buhler 1980 Antihypertensive beta-blockade and the reninangiotensin system Cardiology 66 12 27 6105916 Buhler FR. Antihypertensive beta-blockade and the reninangiotensin system. Cardiology 1980; 66: 12–27
5. 5. J Levi J Coburn C Kleeman 1976 Mechanism of antidiuretic effect of beta-adrenergic stimulation in man Arch Intern Med 136 25 9 2127 10.1001/archinte.1976.03630010015003 1:CAS:528:DyaE28XpvFGntg%3D%3D Levi J, Coburn J, Kleeman C. Mechanism of antidiuretic effect of beta-adrenergic stimulation in man. Arch Intern Med 1976; 136: 25–9
6. 6. H Fogari A Zoppi C Pasotti 1989 Plasma lipids during chronic antihypertensive therapy with different beta-blockers J Cardiovasc Pharmacol 14 7 S28 S32 2481787 Fogari H, Zoppi A, Pasotti C, et al. Plasma lipids during chronic antihypertensive therapy with different beta-blockers. J Cardiovasc Pharmacol 1989; 14 Suppl. 7; S28–S32
7. 7. J Métha P Métha 1982 Effects of propranolol therapy on platelet release and prostaglandin generation in patients with coronary heart disease Circulation 66 1294 9 10.1161/01.CIR.66.6.1294 Métha J, Métha P. Effects of propranolol therapy on platelet release and prostaglandin generation in patients with coronary heart disease. Circulation 1982; 66: 1294–9
8. 8. D Murdoch RN Brogden 1991 Sustained release nifedipine formulations Drugs 41 5 737 79 1712708 10.2165/00003495-199141050-00006 1:STN:280:DyaK3MzgtFSltw%3D%3D Murdoch D, Brogden RN. Sustained release nifedipine formulations. Drugs 1991; 41(5): 737–79
9. 9. EM Sorkin SP Clissold RN Brogden 1985 Nifedipine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders Drugs 30 182 274 2412780 10.2165/00003495-198530030-00002 1:CAS:528:DyaL2MXlvVyqsL0%3D Sorkin EM, Clissold SP, Brogden RN. Nifedipine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders. Drugs 1985; 30: 182–274
10. 10. RM Zusman DM Christensen EB Federman 1989 Nifedipine, but not propranolol, improves left ventricular systolic and diastolic function in patients with hypertension Am J Cardiol 64 11 51F 61F 2782271 10.1016/0002-9149(89)90747-9 1:STN:280:DyaL1MzptVersg%3D%3D Zusman RM, Christensen DM, Federman EB, et al. Nifedipine, but not propranolol, improves left ventricular systolic and diastolic function in patients with hypertension. Am J Cardiol 1989; 64(11): 51F–61F
11. 11. BF Robinson RJ Dobbs CR Kelsey 1980 Effects of nifedipine on resistance vessels arteries and veins in man Br J Clin Pharmacol 10 433 8 7437254 10.1111/j.1365-2125.1980.tb01784.x 1:CAS:528:DyaL3MXps1ahug%3D%3D Robinson BF, Dobbs RJ, Kelsey CR. Effects of nifedipine on resistance vessels arteries and veins in man. Br J Clin Pharmacol 1980; 10: 433–8
12. 12. PC Rubin L Butters R McCabe 1988 Nifedipine and platelets in pre-eclampsia Am J Hypertens 1 175 7 3401356 1:STN:280:DyaL1c3ptlOkug%3D%3D Rubin PC, Butters L, McCabe R. Nifedipine and platelets in pre-eclampsia. Am J Hypertens 1988; 1: 175–7
13. 13. SK Bhatnagear MMA Amin AR Yussuf Al 1984 Diabetogenic effects of nifedipine BMJ 289 19 10.1136/bmj.289.6436.19 Bhatnagear SK, Amin MMA, Al Yussuf AR. Diabetogenic effects of nifedipine. BMJ 1984; 289: 19
14. 14. GP Reams A Hamory A Lali 1988 Effect of nifedipine on renal function in patients with essential hypertension Hypertension 11 452 6 3366479 10.1161/01.HYP.11.5.452 1:STN:280:DyaL1c3ht1Gltw%3D%3D Reams GP, Hamory A, Lali A, et al. Effect of nifedipine on renal function in patients with essential hypertension. Hypertension 1988; 11: 452–6
15. 15. G Bellini G Battilana E Puppis 1984 Renal response to acute nifedipine administration in normotensive and hypertensive patients during normal and low sodium intake Curr Ther Res 35 974 81 Bellini G, Battilana G, Puppis E, et al. Renal response to acute nifedipine administration in normotensive and hypertensive patients during normal and low sodium intake. Curr Ther Res 1984; 35: 974–81
16. 16. K Hiramatsu F Yamagishi T Kubota 1982 Acute effects of the calcium antagonist nifedipine on blood pressure, pulse rate and the renin-angiotensin-aldosterone system in patients with essential hypertension Am Heart J 104 1346 50 6293295 10.1016/0002-8703(82)90166-1 1:STN:280:DyaL3s%2FntFGgsQ%3D%3D Hiramatsu K, Yamagishi F, Kubota T, et al. Acute effects of the calcium antagonist nifedipine on blood pressure, pulse rate and the renin-angiotensin-aldosterone system in patients with essential hypertension. Am Heart J 1982; 104: 1346–50
17. 17. B Dahlöf R Eggersten L Hansson 1988 Calcium antagonists combined with beta-blockers or ACE inhibitors in the treatment of hypertension J Cardiovasc Pharmacol 12 6 S104 S108 2468890 10.1097/00005344-198812006-00026 Dahlöf B, Eggersten R, Hansson L. Calcium antagonists combined with beta-blockers or ACE inhibitors in the treatment of hypertension. J Cardiovasc Pharmacol 1988; 12 Suppl. 6: S104–S108
18. 18. L Steichele 1987 Nif-Ten in the controlled study Münch Med Wschr 129 8 10 Steichele L. Nif-Ten in the controlled study. Münch Med Wschr 1987; 129: 8–10
19. 19. G Jackson JL Thirkettle DJ Taylor 1993 A double-blind crossover trial of atenolol, enalapril and the fixed combination of atenolol and nifedipine in mild and moderate hypertension Br J Clin Pract 47 2 66 70 8334064 1:STN:280:DyaK3szis1Cqug%3D%3D Jackson G, Thirkettle JL, Taylor DJ, et al. A double-blind crossover trial of atenolol, enalapril and the fixed combination of atenolol and nifedipine in mild and moderate hypertension. Br J Clin Pract 1993; 47(2): 66–70
20. 20. TJ Fitzsimons SC Norris HK Adam 1991 A study of the pharmacokinetics and pharmacodynamics of nifedipine in combination with atenolol Biopharm Drug Dispos 12 81 94 2039814 10.1002/bdd.2510120109 1:CAS:528:DyaK3MXnsVKqsA%3D%3D Fitzsimons TJ, Norris SC, Adam HK, et al. A study of the pharmacokinetics and pharmacodynamics of nifedipine in combination with atenolol. Biopharm Drug Dispos 1991; 12: 81–94